Matrix metalloproteinase 9 is involved in airway inflammationin cough variant asthma

Experimental and Therapeutic Medicine

Volumn 8, Issue 4, 2014, Pages 1197-1200

  Ma, Hui Ping ^a   Li, Wei ^a   Liu, Xiao Min ^b  

^a Jining First People's Hospital   (China)

^b THE FIRST AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cough variant asthma; Inflammation; Matrix metalloproteinase 9

Indexed keywords

BUDESONIDE; FLUTICASONE; FORMOTEROL; GELATINASE B; IMMUNOGLOBULIN E; INTERLEUKIN 5; SALMETEROL;

ADULT; ARTICLE; ASTHMA; CLINICAL ARTICLE; CONTROLLED STUDY; COUGH VARIANT ASTHMA; ENZYME LINKED IMMUNOSORBENT ASSAY; EOSINOPHIL COUNT; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INHALATION TEST; LUNG FUNCTION TEST; MALE; PROTEIN EXPRESSION; RESPIRATORY TRACT INFLAMMATION; SPIROMETRY; SPUTUM ANALYSIS;

EID: 84906491784     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1903     Document Type: Article

References (19)

1. Fujimura M, Ogawa H, Nishizawa Y and Nishi K: Comparison of atopic cough with cough variant asthma: is atopic cough a precursor of asthma? Thorax 58: 14-18, 2003.
2. Lai K, Chen R, Lin J, et al: A prospective, multicenter survey on causes of chronic cough in China. Chest 143: 613-620, 2013
3. Matsumoto H, Niimi A, Tabuena RP, et al: Airway wall thickening in patients with cough variant asthma and nonasthmatic chronic cough. Chest 131: 1042-1049, 2007.
4. Niimi A: Structural changes in the airways: cause or effect of chronic cough? Pulm Pharmacol Ther 24: 328-333, 2011.
5. Bratcher PE, Weathington NM, Nick HJ, et al: MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro. PLoS One 7: e41881, 2012.
6. Vandenbroucke RE, Dejonckheere E and Libert C: A therapeutic role for matrix metalloproteinase inhibitors in lung diseases? Eur Respir J 38: 1200-1214, 2011.
7. Chaudhuri R, McSharry C, Brady J, et al: Sputum matrix metalloproteinase-12 in patients with chronic obstructive pulmonary disease and asthma: relationship to disease severity. J Allergy Clin Immunol 129: 655-663, 2012.
8. Oka S, Furukawa H, Shimada K, et al: Serum biomarker analysis of collagen disease patients with acute-onset diffuse interstitial lung disease. BMC Immunol 14: 9, 2013.
9. Hu C, Wang J, Xu Y, et al: Current evidence on the relationship between five polymorphisms in the matrix metalloproteinases (MMP) gene and lung cancer risk: a meta-analysis. Gene 517: 65-71, 2013.
10. Craig VJ, Quintero PA, Fyfe SE, et al: Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury. J Immunol 190: 4283-4296, 2013.
11. Ko FW, Diba C, Roth M, et al: A comparison of airway and serum matrix metalloproteinase-9 activity among normal subjects, asthmatic patients, and patients with asthmatic mucus hypersecretion. Chest 127: 1919-1927, 2005.
12. Castano R, Miedinger D, Maghni K, et al: Matrix metalloproteinase-9 increases in the sputum from allergic occupational asthma patients after specific inhalation challenge. Int Arch Allergy Immunol 160: 161-164, 2013.
13. Hong Z, Lin YM, Qin X and Peng JL: Serum MMP-9 is elevated in children with asthma. Mol Med Rep 5: 462-464, 2012.
14. Page K, Ledford JR, Zhou P and Wills-Karp M: A TLR2 agonist in German cockroach frass activates MMP-9 release and is protective against allergic inflammation in mice. J Immunol 183: 3400-3408, 2009.
15. Asthma Workgroup, Chinese Society, Respiratory, Diseases (CSRD), Chinese Medical, Association. The Chinese national guidelines on diagnosis and management of cough (December 2010). Chin Med J (Engl) 124: 3207-3219, 2011.
16. De Diego A, Martínez E, Perpiñá M, et al: Airway inflammation and cough sensitivity in cough-variant asthma. Allergy 60: 1407-1411, 2005.
17. Yoo Y, Koh YY, Kang H, et al: Sputum eosinophil counts and eosinophil cationic protein levels in cough-variant asthma and in classic asthma, and their relationships to airway hypersensitivity or maximal airway response to methacholine. Allergy 59: 1055-1062, 2004.
18. Yang MS, Lee HS, Kim MH, et al: Rhinitis patients with sputum eosinophilia show decreased lung function in the absence of airway hyperresponsiveness. Allergy Asthma Immunol Res 5: 232-238, 2013.
19. de Borja Callejas F, Picado C, Martínez-Antón A, et al: Differential expression of remodeling markers by tissue structure in nasal polyposis. Am J Rhinol Allergy 27: e69-e74, 2013.